Summary
The parasite Trichinella spiralis survives in its host by releasing products that dampen the immune response - and those same molecules, the ESL1 antigens, show promise for treating autoimmune diseases such as multiple sclerosis. The open question is timing: in a natural infection the antigens arrive gradually, and this study asks whether reproducing that controlled release improves the therapeutic effect. The antigens were encapsulated in biodegradable electrospun PLGA nanofibres, turning a parasite's evasion strategy into a delivery schedule.
Authors & Affiliations
Linari Electrospinning Systems
Linari Engineering electrospinning system
The nanofibres were prepared on a Linari Engineering system (Pisa, Italy), with the electrospinning conditions adjusted to obtain fine, uniform fibres suitable for antigen encapsulation. The paper does not name the model; see our range of electrospinning systems.